Objective:

To explore the relationship between Demodex infestation, meibomian gland dysfunction (MGD), and contact lens dropout.

Approach:

• Demodex and MGD Correlation: Investigated the prevalence of Demodex mites and MGD in contact lens wearers, highlighting their impact on comfort and wear time.
• Diagnosis and Treatment: Described diagnostic methods for Demodex blepharitis and treatment options, including lotilaner and ivermectin.

Key Findings:

• 93% of soft contact lens dropout patients have Demodex infestation.
• Less than 6% of patients with Demodex on lid margins report no discomfort.
• 57% of patients with MGD also have Demodex blepharitis.
• 60% of contact lens wearers exhibit MGD.
• Lotilaner 0.25% is FDA-approved for eradicating Demodex mites.

Interpretation:

The presence of Demodex mites and MGD significantly contributes to contact lens discomfort and dropout.

Limitations:

• The article does not address the long-term efficacy of treatments.
• Limited discussion on alternative causes of contact lens dropout.

Conclusion:

Effective treatments targeting Demodex and MGD can potentially reduce contact lens dropout rates.

Sources:

• Clinical Factors Associated with Contact Lens Dropout
• Demodex Blepharitis Prevalence Study
• Lotilaner Ophthalmic Solution Study